[Conservative therapy in the Parkinson syndrome].
D000547:Amantadine / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D007275:Injections, Intravenous; D009069:Movement Disorders / Q000209:etiology; D009325:Nausea / Q000209:etiology; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D000928:Antidepressive Agents; D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D007099:Imipramine
Die konservative Therapie des Parkinson-Syndroms.